Newsroom
Sorted by: Latest
-
DAR Investment Management Acquires Intecsa Engineering Group to Accelerate U.S. Growth
MADRID & WILMINGTON, Del.--(BUSINESS WIRE)--DAR Investment Management (“DAR”), a private investment firm, today announced the strategic acquisition of a controlling interest in Intecsa Engineering Group (“Intecsa” or the “Company”), a global engineering and consulting firm with more than 60 years of experience delivering complex transportation, water, environmental, and civil infrastructure projects worldwide. Intecsa’s management team and employees will retain a significant ownership stake in...
-
Yahoo Selects Navan to Modernize Travel and Expense Program
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the leading all-in-one business travel, payments, and expense management platform, today announced it has been selected by Yahoo as its unified travel and expense management platform. This partnership marks a significant milestone in Yahoo’s ongoing business transformation as it adopts Navan’s modern, AI-driven platform. “At Yahoo, we’re embedding AI and data-driven capabilities across our iconic products and business operations, includi...
-
Vantage Corp Restructures its IT Business and Assets to New Subsidiary Hadō Pte Ltd
SINGAPORE--(BUSINESS WIRE)--Vantage Corp (NYSE American: VNTG) (“Vantage” or the “Company”), a shipbroking company providing comprehensive services including brokerage, consultancy, and operational support in the tanker market, today announced the successful reorganization of its IT business and the transfer of related assets to a newly incorporated private limited company in Singapore, Hadō Pte Ltd (“Hadō”). Hadō is a newly established, wholly-owned subsidiary of Vantage (BVI) Corporation, the...
-
IMAX Corporation to Announce Fourth-Quarter and Full-Year 2025 Financial Results and Host Conference Call
NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced it will hold a conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, February 25th at 4:30 p.m. Eastern Time. This call is being webcast and can be accessed at https://www.imax.com/content/investor-relations. To access the call via telephone, interested parties will need to pre-register by going to the following link: https://edge.media-server.com/mmc/p/jcmz974h where you will be...
-
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks. Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the United...
-
Spok Earns Top Client Satisfaction Scores for Ninth Consecutive Year
PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, achieved the top honors for the ninth consecutive year in a survey of healthcare industry clients by Black Book Market Research on top-rated secure messaging and clinical communications solutions. Additionally, for the second consecutive year, Spok has been named as the leading performer of critical alert messaging and management solutions. “These...
-
Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, has granted approval for its clinical trial application (CTA) for Study SRP-1005-101, also known as INSIGHTT. Sarepta expects to initiate this first-in-human clinical trial of SRP-1005 (formerly ARO-HTT) in the second quarter of 2026. SRP-1005 is an investigational sm...
-
Fortem’s AI-powered SkyDome® Neutralizes Drone Swarm With Zero Collateral Damage
LINDON, Utah--(BUSINESS WIRE)--Fortem Technologies, the global leader in airspace security and counter-drone solutions, today announced it has completed what it believes is the first autonomous 5-vs-5 drone intercept with safe capture of every target, demonstrating a scalable counter-swarm defense capability as hostile drone attacks grow increasingly coordinated. In a live test, five DroneHunter® F700 interceptors operating under the command of a single SkyDome® system – Fortem’s AI-powered sof...
-
Shipfusion Acquisition of Boxtrot Highlights Record Year
CHICAGO--(BUSINESS WIRE)--Shipfusion completes acquisition of Boxtrot, integrating merchants into its fulfillment network and capping a record year of ecommerce growth....
-
Global Payments to Report Fourth Quarter and Full Year 2025 Results on February 18, 2026
ATLANTA--(BUSINESS WIRE)--Global Payments Inc. will release fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 18, 2026....